Cardinal Health (NYSE:CAH) Issues FY25 Earnings Guidance

Cardinal Health (NYSE:CAH – Get Free Report) issued an update on its FY25 earnings guidance on Wednesday morning. The company provided EPS guidance of $7.55-7.70 for the period, compared to the consensus EPS estimate of $7.53. Cardinal Health also updated its FY 2025 guidance to 7.550-7.700 EPS. Wall Street Analysts Forecast Growth CAH has been […]

Leave a Reply

Your email address will not be published.

Previous post HC Wainwright Reaffirms “Buy” Rating for Dianthus Therapeutics (NASDAQ:DNTH)
Next post Intapp (NASDAQ:INTA) Releases Q1 Earnings Guidance